Follow Healthline   |   Healthline on TwitterTwitter   |   Healthline on FacebookFacebook
Symptom Search   |   Treatment Search   |   Doctor Search   |   Drug Search

Drug Notebook

Generic Name: capecitabine

View All Brands
Xeloda
An antimetabolite - It slows the growth of cancer cells
Search Drug Notebook
Hide
Your search results:
Search the capecitabine Drug Notebook
FDA Alerts

    Alterations in Anticoagulant Effects
  • Altered coagulation parameters (e.g., increased PT, increased INR) and/or bleeding, sometimes fatal, reported in patients, with or without liver metastases, receiving capecitabine concomitantly with coumarin-derivative anticoagulants. Generally occurs within several days to months following initiation of therapy, but has been reported within 1 month following discontinuance of therapy. (See Coagulopathy under Cautions and also see Specific Drugs under Interactions.)
  • Age >60 years and diagnosis of cancer may independently increase risk of coagulopathy.
  • Monitor anticoagulant response (PT or INR) frequently in patients receiving concomitant capecitabine and oral coumarin-derivative therapy; adjust anticoagulant dosage accordingly.

Media Gallery
Drug Info Tools
Search by color, shape and markings. click here
Check any 2 drugs for interactions. click here
Compare any two drugs side by side. click here
Medicare's drug plans are subsidized by the US federal government and offered through insurers.
Advertisement
Marketplace
capecitabine
(ka pe SITE a been)
XELODA / 500 | 500 mgXELODA / 500   500 mg
bottle, 240 each Capecitabine 500mg, Oral tablet, peach, biconvex, oblong-shaped, side 1:XELODA, side 2:500
XELODA / 150 | 150 mgXELODA / 150   150 mg
bottle, 60 each Capecitabine 150mg, Oral tablet, peach, biconvex, oblong-shaped, side 1:XELODA, side 2:150
Back to Top